Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Capital Expenditures (2016 - 2021)

Cavitation Technologies' Capital Expenditures history spans 8 years, with the latest figure at $250000.0 for Q3 2021.

  • On a quarterly basis, Capital Expenditures rose 233.33% to $250000.0 in Q3 2021 year-over-year; TTM through Sep 2022 was $253000.0, a 16.5% decrease, with the full-year FY2021 number at $128000.0, up 156.0% from a year prior.
  • Capital Expenditures hit $250000.0 in Q3 2021 for Cavitation Technologies, up from $3000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for CVAT hit a ceiling of $250000.0 in Q3 2021 and a floor of $1000.0 in Q2 2019.
  • Historically, Capital Expenditures has averaged $71500.0 across 3 years, with a median of $50000.0 in 2020.
  • Biggest five-year swings in Capital Expenditures: soared 4900.0% in 2020 and later crashed 94.0% in 2021.
  • Tracing CVAT's Capital Expenditures over 3 years: stood at $1000.0 in 2019, then soared by 4900.0% to $50000.0 in 2020, then surged by 400.0% to $250000.0 in 2021.
  • Business Quant data shows Capital Expenditures for CVAT at $250000.0 in Q3 2021, $3000.0 in Q2 2021, and $50000.0 in Q4 2020.